Santhera Pharmaceuticals (Schweiz) AG – Trademark Portfolio
Entity Type: 03
Santhera Pharmaceuticals (Schweiz) AG holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include RAXONE, AGAMREE, PULDYSA, and SANTHERA. The owner is based in 4410 Liestal.
Hammerstrasse 47
4410 Liestal , CH
Showing of trademarks Trademarks
Trademark Classifications
Santhera Pharmaceuticals (Schweiz) AG's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does Santhera Pharmaceuticals (Schweiz) AG have?
Santhera Pharmaceuticals (Schweiz) AG has 13 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 3 abandoned, 5 cancelled.
What trademark classes does Santhera Pharmaceuticals (Schweiz) AG file in?
Santhera Pharmaceuticals (Schweiz) AG files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Santhera Pharmaceuticals (Schweiz) AG's most well-known trademarks?
Santhera Pharmaceuticals (Schweiz) AG's registered trademark portfolio includes well-known marks such as RAXONE, AGAMREE, PULDYSA, and SANTHERA. These are among 4 currently registered trademarks in the portfolio.
What is Santhera Pharmaceuticals (Schweiz) AG's trademark registration success rate?
Santhera Pharmaceuticals (Schweiz) AG has a 33% trademark registration rate, with 4 out of 12 resolved applications resulting in successful registration. Currently, 1 application is pending review.